Eli Lilly shares jump on two big updates and Jim Cramer is so here for it

• Jim Cramer identifies an interesting buy level for our worst performing Big Tech stock this year

  Business - CNBC - October 31

• Jim Cramer's big takeaway from the market reaction to Nvidia's earnings beat

  Business - CNBC - 5 days ago
• 

  Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

  Business - Financial Times - October 30

• Best Buy rallies ahead earnings, Black Friday — but here's why we're still cautious

  Business - CNBC - Yesterday

• Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

  Business - CNBC - October 30

• Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise

  Business - CNBC - November 8

• Cramer says 'so many things are working' in the market. Here are a few bright spots

  Business - CNBC - November 8

More from CNBC

• Israel-Hezbollah permanent ceasefire has been accepted, Biden says

  Business - CNBC - 9 hours ago

• OpenAI gets new $1.5 billion investment from SoftBank, allowing employees to sell shares in a tender offer

  Business - CNBC - 2 hours ago

• 'Europe's Detroit' built a thriving car industry. Trump tariffs now threaten to unravel its success

  Business - CNBC - 1 hour ago

• China's industrial profits fall by 10% in October as deflation worries linger

  Business - CNBC - 2 hours ago

• 32-year-old American in Denmark, one of the world’s happiest countries: The No. 1 thing I’ve learned about building a rich life

  Business - CNBC - 16 hours ago